Prasterone
- Generic Name
- Prasterone
- Brand Names
- Intrarosa
- Drug Type
- Small Molecule
- Chemical Formula
- C19H28O2
- CAS Number
- 53-43-0
- Unique Ingredient Identifier
- 459AG36T1B
- Background
Prasterone, also known as dehydroepiandrosterone (DHEA) is a major C19 steroid produced by the adrenal cortex. It is also produced in small quantities in the testis and the ovary. Dehydroepiandrosterone (DHEA) can be converted to testosterone; androstenedione; estradiol; and estrone. Most of DHEA is sulfated (dehydroepiandrosterone sulfate) before secretion....
- Indication
DHEA is taken as a supplement for a variety of unsubstantiated indications. The following indications have shown promise and are backed up by some scientific evidence: schizophrenia (DHEA may be more effective in women than men); improving the appearance of older people’s skin (taking DHEA by mouth seems to increase skin thickness and moisture, and decrease ...
- Associated Conditions
- Moderate Dyspareunia, Severe Dyspareunia
- Associated Therapies
- -
Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial
- Conditions
- Interventions
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 108
- Registration Number
- NCT05935761
- Locations
- 🇺🇸
Durham VA Medical Center, Durham, NC, Durham, North Carolina, United States
The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders
- Conditions
- Interventions
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2023-07-18
- Lead Sponsor
- Beni-Suef University
- Target Recruit Count
- 300
- Registration Number
- NCT05900661
- Locations
- 🇪🇬
Beni-suef university Hospital, Banī Suwayf, Beni Suef, Egypt
GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.
- Conditions
- Interventions
- First Posted Date
- 2022-09-30
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 160
- Registration Number
- NCT05562518
- Locations
- 🇧🇪
University Hospital Ghent, Gent, Belgium
Does DHEA IVF Outcomes in Poor Responders?
- Conditions
- Interventions
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2022-06-23
- Target Recruit Count
- 400
- Registration Number
- NCT04066478
- Locations
- 🇬🇧
Homerton Fertility Centre, London, United Kingdom
Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
- Conditions
- Interventions
- First Posted Date
- 2019-02-26
- Last Posted Date
- 2021-06-30
- Lead Sponsor
- Olivia Cardenas-Trowers, M.D.
- Registration Number
- NCT03854396
- Locations
- 🇺🇸
University of Louisville Urogynecology at Springs Medical Center, Louisville, Kentucky, United States
Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2022-06-09
- Lead Sponsor
- San Diego Sexual Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT03568604
- Locations
- 🇺🇸
San Diego Sexual Medicine, San Diego, California, United States
Neurosteroids in PTSD - Biomarkers to Therapeutics
- First Posted Date
- 2018-04-06
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 5
- Registration Number
- NCT03491007
- Locations
- 🇺🇸
Durham VA Medical Center, Durham, NC, Durham, North Carolina, United States
The Effects of Fluoxetine And/or DHEA
- Conditions
- Interventions
- First Posted Date
- 2017-07-25
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 60
- Registration Number
- NCT03228732
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles
- First Posted Date
- 2016-08-15
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Target Recruit Count
- 78
- Registration Number
- NCT02866253
Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI
- Conditions
- Interventions
- First Posted Date
- 2016-05-10
- Last Posted Date
- 2018-01-03
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 230
- Registration Number
- NCT02766764
- Locations
- 🇪🇬
Cairo university hospitals, Cairo, Egypt
🇪🇬Dar AlTeb subfertility centre, Cairo, Egypt
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.